drugset / Trial / NCT00857753

Relative Bioavailability of a Fentanyl Patch

NCT00857753

Phase 1 Completed 40 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

Tohe purpose of this study is to demonstrate the bioequivalence of a fentanyl patch transdermal delivery system.

Timeline

Start
2006-09
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 25 ug Other

Indications

No indication recorded.